JENNIFER BUSH: Open Payments
NPI 1255664918 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 77 payments from 15 companies in 2025. Trend: 2023 $2,021 · 2024 $2,513 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 18 | $393 |
| ABBVIE INC. | 13 | $350 |
| Gilead Sciences, Inc. | 10 | $231 |
| Merck Sharp & Dohme LLC | 9 | $184 |
| Aimmune Therapeutics, Inc. | 4 | $113 |
| Melinta Therapeutics, LLC | 4 | $91 |
| Ferring Pharmaceuticals Inc. | 3 | $84 |
| Paratek Pharmaceuticals, Inc. | 4 | $63 |
| Astellas Pharma US Inc | 2 | $62 |
| Insmed, Inc. | 2 | $57 |
Products named: CABENUVA, MAVYRET, DOVATO, EMBLAVEO, PIFELTRO, VOWST, Rezzayo, REBYOTA.
Industry payments across FL — which companies pay providers there.
